These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38833439)

  • 41. Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients.
    Taran FA; Wallwiener M; Kabashi D; Rothmund R; Rall K; Kraemer B; Brucker SY
    Arch Gynecol Obstet; 2012 Jun; 285(6):1571-6. PubMed ID: 22193824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance.
    Filip G; Balzano A; Cagnacci A
    Minerva Ginecol; 2019 Jun; 71(3):177-181. PubMed ID: 30486633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uterine artery ligation for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section.
    Liu WM; Wang PH; Tang WL; Wang IT; Tzeng CR
    Fertil Steril; 2006 Aug; 86(2):423-8. PubMed ID: 16762346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
    Borah BJ; Laughlin-Tommaso SK; Myers ER; Yao X; Stewart EA
    Obstet Gynecol; 2016 Jan; 127(1):67-77. PubMed ID: 26646122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenomyosis interferes with accurate ultrasonographic detection of uterine leiomyomas.
    Harmanli OH; Bevilacqua SA; Dandolu V; Chatwani AJ; Hernandez E
    Arch Gynecol Obstet; 2005 Dec; 273(3):146-9. PubMed ID: 16001190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-existence of uterine myomas and endometriosis in women undergoing laparoscopic myomectomy: risk factors and surgical implications.
    Maclaran K; Agarwal N; Odejinmi F
    J Minim Invasive Gynecol; 2014; 21(6):1086-90. PubMed ID: 24905479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
    Zurawin RK; Fischer JH; Amir L
    J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of extracellular matrix proteins on T-cell proliferation and apoptosis in women with endometriosis or uterine leiomyoma.
    Chrobak A; Gmyrek GB; Sozański R; Sieradzka U; Paprocka M; Gabryś M; Jerzak M
    Am J Reprod Immunol; 2004 Feb; 51(2):123-9. PubMed ID: 14748838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uterine artery occlusion and myomectomy for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section.
    Lin JY; Lee WL; Wang PH; Lai MJ; Chang WH; Liu WM
    J Obstet Gynaecol Res; 2010 Apr; 36(2):284-90. PubMed ID: 20492378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of laparoscopic uterine nerve ablation to laparoscopic bipolar coagulation of uterine vessels for women with uterine myomas and dysmenorrhea.
    Yen YK; Liu WM; Yuan CC; Ng HT
    J Am Assoc Gynecol Laparosc; 2001 Nov; 8(4):573-8. PubMed ID: 11677339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gynaecological pathologies leading to emergency department admissions: A cross-sectional study.
    Xholli A; Londero AP; Camacho Mattos L; Vujosevic S; Cagnacci A
    Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():38-42. PubMed ID: 36630817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal exposure to mixtures of xenoestrogens and repetitive element DNA methylation changes in human placenta.
    Vilahur N; Bustamante M; Byun HM; Fernandez MF; Santa Marina L; Basterrechea M; Ballester F; Murcia M; Tardón A; Fernández-Somoano A; Estivill X; Olea N; Sunyer J; Baccarelli AA
    Environ Int; 2014 Oct; 71():81-7. PubMed ID: 24980756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association between heavy metals, endometriosis and uterine myomas among premenopausal women: National Health and Nutrition Examination Survey 1999-2002.
    Jackson LW; Zullo MD; Goldberg JM
    Hum Reprod; 2008 Mar; 23(3):679-87. PubMed ID: 18192673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding cellular leiomyomas: a case-control study.
    Taran FA; Weaver AL; Gostout BS; Stewart EA
    Am J Obstet Gynecol; 2010 Aug; 203(2):109.e1-6. PubMed ID: 20451890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of postmenopausal uterine leiomyomas: Focus on variants.
    Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
    J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Semiquantitative analysis of mRNA aromatase expression in eutopic endometrium as a diagnostic marker of endometriosis and estrogen dependent diseases].
    Visnovský J; Galo S; Zúbor P; Hatok J; Racay P; Danko J
    Ceska Gynekol; 2008 Jul; 73(4):213-7. PubMed ID: 18711959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uterine leiomyomas, serum cholesterol, and oral contraceptives. A preliminary study of epidemiologic differences in Los Angeles, California and Albany, New York.
    Ratech H; Stewart ME
    Diagn Gynecol Obstet; 1982; 4(1):21-4. PubMed ID: 7075443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy.
    Grigoriadis C; Papaconstantinou E; Mellou A; Hassiakos D; Liapis A; Kondi-Pafiti A
    Clin Exp Obstet Gynecol; 2012; 39(2):191-4. PubMed ID: 22905461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.